Floatz logo

Opc-34712

Sleep Disturbances

H. Lundbeck A/SPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Sleep Disturbances cohort.

Asset / SponsorPhaseRating
Trazodone
Johns Hopkins University
Phase 4BB
Armodafinil
Cephalon
Phase 4BB
Tvp-1012
Technische Universität Dresden
Phase 4BB
MELATONIN
Duke University
Phase 3BB
Olanzapine
Central Institute of Psychiatry, Ranchi, India
Phase 4BB

View all 36 →

Same molecule, other indications

Opc-34712 is also rated in:

depressive disorderDormant
A
Indicative ·
82 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
75 / 100
View asset →
schizophreniaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →